These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12705804

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM, Kirchhof B, Gottstein C.
    Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.
    Miller JW, Adamis AP, Aiello LP.
    Diabetes Metab Rev; 1997 Mar; 13(1):37-50. PubMed ID: 9134347
    [No Abstract] [Full Text] [Related]

  • 5. [Cell biology of intraocular vascular diseases].
    Ishibashi T.
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [Abstract] [Full Text] [Related]

  • 6. Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation.
    Gale NW, Thurston G, Davis S, Wiegand SJ, Holash J, Rudge JS, Yancopoulos GD.
    Cold Spring Harb Symp Quant Biol; 2002 Dec; 67():267-73. PubMed ID: 12858549
    [No Abstract] [Full Text] [Related]

  • 7. [Angiogenesis and inhibition of angiogenesis in the eye].
    Cursiefen C, Schönherr U.
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):341-51. PubMed ID: 9333658
    [Abstract] [Full Text] [Related]

  • 8. [Risk factors for diabetic complications: Angiogenesis factor].
    Katsura Y.
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():73-8. PubMed ID: 12430210
    [No Abstract] [Full Text] [Related]

  • 9. Shedding light on blindness.
    Barinapa M.
    Science; 1995 Jan 27; 267(5197):452-3. PubMed ID: 7824943
    [No Abstract] [Full Text] [Related]

  • 10. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization.
    Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, Kahn CR.
    J Clin Invest; 2003 Jun 27; 111(12):1835-42. PubMed ID: 12813019
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C, Ortega N, Bayard F, Plouet J.
    Diabetes Metab; 1996 Jul 27; 22(4):268-73. PubMed ID: 8767174
    [Abstract] [Full Text] [Related]

  • 14. New concepts in pathogenesis and treatment of diabetic retinopathy.
    Spranger J, Pfeiffer AF.
    Exp Clin Endocrinol Diabetes; 2001 Jul 27; 109 Suppl 2():S438-50. PubMed ID: 11460590
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Role of vascular endothelial growth factor in microvascular abnormalities in diabetic retinopathy].
    Takagi H.
    Nihon Ronen Igakkai Zasshi; 2000 Aug 27; 37(8):603-6. PubMed ID: 11086383
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Angiogenic inducers and inhibitors].
    Shukunami C, Hiraki Y.
    Tanpakushitsu Kakusan Koso; 2000 Sep 27; 45(13 Suppl):2131-8. PubMed ID: 11021214
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.